<script> window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'UA-48293608-1'); </script>
Logo-bi
Bioimpacts. 2025;15: 30996 | Published on: 2025 Aug 27. doi: 10.34172/bi.30996
PMID: 41064391        PMCID: PMC12501477

Review

Revolutionizing cancer therapy: Monoclonal antibodies in radiosensitization

Abolfazl Bemidinezhad 1,2,3, Yasaman Abolhassani 4, Mojgan Noroozi-Karimabad 1, Arman Abroumand Gholami 5, Abbas Alalikhan 3,6,7, Ramin Roshani 8, Mohammad Parsa-kondelaji 9, Fatemeh Gheybi 4,10 * ORCID

Cited by CrossRef: 1

1- Safari M, Farahani N, Faghih Ojaroodi A, Ebrahimpour A, Cho W, Zare Khormizi F, Mafi A, Raesi R, Mohammad-Sadeghipour M, Alimohammadi M, Hushmandi K, Hashemi M, Taheriazam A. Long non-coding RNAs and therapeutic resistance in multiple myeloma: from molecular insights to clinical applications. Clin Exp Med. 2026;26(1) [Crossref]
2- Tanaschuk E, Abolhassani Y, Mohammadi N, Alalikhan A, Roshani R, Bemidinezhad A. Leveraging perfluorocarbon nanoparticles to overcome tumor hypoxia and enhance radiotherapy efficacy. Journal of Drug Delivery Science and Technology. 2026;122:108417 [Crossref]
3- Mahdi E, Alalikhan A, Ridha-Salman H, Azeez Ameen M, Hannon Abbass Z, Bemidinezhad A, Soukhtanloo M. Perfluorocarbon nanotechnologies for blood-brain barrier modulation: Enhancing drug delivery and neuroprotection. Biochemical and Biophysical Research Communications. 2025;789:152843 [Crossref]
4- Bemidinezhad A, Al-Baghdadi A, Alsarray A, Abolhassani Y, Kenjayev Y, Gheybi F, Higuchi A. Enhancing Radiotherapy for Hypoxic Tumors: Integrative Strategies Using Bacteria and Nanoparticles. IET Nanobiotechnology. 2025;2025(1) [Crossref]
5- Gupta J, Al-dulaimi A, Kadhem M, Ahmad I, Jyothi S, Panigrahi R, Singh I, Singh S, Muften N, Mustafa Y. Catalase-powered Micro/Nanorobots: Propulsion Mechanisms and Biomedical, Environmental, and Industrial Applications. J Bionic Eng. 2026;23(1):34 [Crossref]
6- Kenjayev Y, Khalikova N, Eshqobilov O, Axmedov U, Babamuratov A, Xursanov A. Utilizing pH-sensitive nanoparticles in cancer radiotherapy: mechanisms and therapeutic potential. J Nanopart Res. 2026;28(2) [Crossref]

Poster

As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences. 
Acceptance rate (2024): 19% 
Publication fee: Free of charge

Indexing/Abstracting Info
PubMed; PubMed Central; Scopus; Science Citation Index Expanded; Google Scholar;   SJR; Essential Science Indicators; Embase; EBSCOhost; CAS: DOAJ: SHERPA/RoMEO
Member of   
Follower of ICMJE
Permission: Creative Commons